(R)-(-)-2,3,7,7a-Tetrahydro-7a-methyl-1H-indene-1,5(6H)-dione>98.0%(GC)1g

2-Amino-1-[4-(2-benzyloxyethyl)piperazin-1-yl]-ethanone dihydrochloride, 98.0%, 5g

EDOT, 97.0%, 100g

(R)-(-)-alpha-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-4-hydroxybenzeneacetic Acid>98.0%(HPLC)(T)5g

(S)-2-Amino-4-methyl-N-(4-nitrophenyl)pentanamide, 95.0%, 250mg

5,5',5''-((1,3,5-Triazine-2,4,6-triyl)tris(azanediyl))triisophthalic acid, 97%, 5g

Methyl N-acetyl-L-tryptophanate, 95.0%, 5g

tert-Butyl 2-bromo-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxylate, 95.0%, 1g

7-Bromo-5-methoxy-2,3-dihydro-1H-inden-1-one, 98%, 1g

1-(Furan-2-yl)-2-methylpropan-1-one, 98%, 100mg

4-(3-CYCLOPROPYL-1,2,4-OXADIAZOL-5-YL)BENZOIC ACID, 95.0%, 1g

ethyl 5-(4-bromophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 2g

3-Bromo-4-nitro-1H-pyrazole, 95.0%, 10g